These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2016-004580-39 Treatment of Growth Hormone Deficiency associated with Chronic Heart Failure: A Randomized, Double-Blind, Placebo-Controlled Study TRATTAMENTO DEL DEFICIT DI GH ASSOCIATO AD INSUFFICIENZA CARDIACA ... not-yet-due
Exempt 2017-000687-16 Novel avenues for the rescue of intellectual disability in Down syndrome NUOVE STRATEGIE PER IL RECUPERO DELLA DISABILIT¿ INTELLETTIVA NELLA SINDROME DI DOWN not-yet-due
Completed, but no date 2017-001261-25 PHARMACOLOGICAL, NO PROFIT, PROSPECTIVE RANDOMIZED, DOUBLE-BLIND PLACEBO, CONTROLLED STUDY TO EVALUATE THE EFFICACY OF LEVOTHYROXINE AND LIOTIRONINE (LT4+LT3) IN POST-SURGICAL HYPOTHYROIDISM PATIENTS... bad-data
Ongoing 2019-002202-43 Effects of empagliflozin on cardiac remodeling and myocardial sympathetic nervous system in diabetic patients affected by chronic heart failure Effetti di empagliflozin sul rimodellamento cardiaco ... not-yet-due
Ongoing 2019-002391-13 Platelet inhibition with Ticagrelor 60 mg versus Ticagrelor 90 mg twice daily in elderly patients with acute coronary syndrome (ACS). Inibizione dell'aggregazione piastrinica con Ticagrelor 60 mg v... not-yet-due
Ongoing 2020-005908-18 Functional-genetic stratification as a guide to personalized treatment in developmental and epileptic encephalopathies due to potassium channel mutations Stratificazione genetico-funzionale come gu... not-yet-due